Clinical Trial Update: Human Biomarkers for Assessing Copper Deficiency [Phase 1]

View source ↗

Summary

Purdue University reports a Phase 1 study investigating human biomarkers for assessing copper deficiency.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Copper Deficiency

Snippet

Sponsor: Purdue University | Conditions: Copper Deficiency | Phase 1 | Status: UNKNOWN